{
  "ticker": "SIG.AX",
  "company": "Sigma Healthcare",
  "sector": "Healthcare",
  "market_cap": null,
  "hypotheses": {
    "T1": {
      "label": "Network Growth",
      "description": "Sigma Healthcare executes on growth strategy; earnings accelerate",
      "plain_english": "This is the bull case — Sigma Healthcare delivers on its key initiatives and the market rewards it.",
      "what_to_watch": "Next earnings result and forward guidance.",
      "upside": "Material re-rating if execution surprises to the upside.",
      "risk_plain": "If growth disappoints, this narrative weakens.",
      "survival_score": 0.5,
      "status": "MODERATE",
      "weighted_inconsistency": 3,
      "last_updated": "2026-02-16T06:49:06.287Z"
    },
    "T2": {
      "label": "Cash Burn Risk",
      "description": "Sigma Healthcare delivers steady-state results; valuation holds",
      "plain_english": "The company continues on its current trajectory — neither surprising positively nor negatively.",
      "what_to_watch": "Margin trends and competitive dynamics.",
      "upside": null,
      "risk_plain": "If the base case is already priced in, limited upside from here.",
      "survival_score": 0.6,
      "status": "MODERATE",
      "weighted_inconsistency": 2,
      "last_updated": "2026-02-16T06:49:06.287Z"
    },
    "T3": {
      "label": "Competition Intensifies",
      "description": "Sigma Healthcare faces headwinds; earnings or multiples compress",
      "plain_english": "This is the bear case — something goes wrong and the stock de-rates.",
      "what_to_watch": "Cost pressures, competitive threats, or macro headwinds.",
      "upside": null,
      "risk_plain": "Material downside if multiple risks crystallise simultaneously.",
      "survival_score": 0.3,
      "status": "LOW",
      "weighted_inconsistency": 4,
      "last_updated": "2026-02-16T06:49:06.287Z"
    },
    "T4": {
      "label": "AI Analytics Moat",
      "description": "A structural shift changes the investment case for Sigma Healthcare",
      "plain_english": "An external force — technology, regulation, or competition — fundamentally alters the business.",
      "what_to_watch": "Industry disruption signals and regulatory changes.",
      "upside": null,
      "risk_plain": "If disruption materialises, prior assumptions become invalid.",
      "survival_score": 0.15,
      "status": "LOW",
      "weighted_inconsistency": 5,
      "last_updated": "2026-02-16T06:49:06.287Z"
    }
  },
  "dominant": "T2",
  "confidence": "LOW",
  "alert_state": "NORMAL",
  "current_price": 2.94,
  "big_picture": "Sigma Healthcare (ASX: SIG) — coverage initiated. Full analysis pending.",
  "last_flip": null,
  "narrative_history": [],
  "evidence_items": [],
  "price_signals": [],
  "editorial_override": null,
  "price_history": [],
  "weighting": null,
  "gics_sub_industry": "Health Care Distributors",
  "narrative_model": "HEALTHCARE_PHARMACY",
  "narrative_weights": {
    "macro": 0.03,
    "sector": 0.02,
    "tech": 0.1,
    "company": 0.85
  },
  "commodity_overlay": null,
  "priceHistory": [
    3,
    2.99,
    2.98,
    3.02,
    2.95,
    2.94
  ],
  "freshness": {
    "pricePctChange": -0.3,
    "urgency": 0,
    "status": "OK",
    "badge": "ok"
  },
  "last_price_update": "2026-02-20T06:11:55.435Z",
  "last_research_update": "2026-02-20T06:11:55.531Z",
  "three_layer_signal": {
    "date": "2026-02-19",
    "macro_signal": 12,
    "sector_signal": 0,
    "tech_signal": 0,
    "idio_signal": -24,
    "company_signal": -24,
    "overall_sentiment": -20,
    "sentiment_label": "DOWNSIDE",
    "macro_contribution": 0,
    "sector_contribution": 0,
    "tech_contribution": 0,
    "company_contribution": -20,
    "idio_contribution": -20,
    "sector_detail": {
      "signal": 0,
      "detail": "company_dominant"
    },
    "idio_detail": {
      "signal": -24,
      "detail": "dominance_sqrt",
      "T1": "T2",
      "T1_score": 33,
      "T1_sentiment": "BEARISH",
      "T2": "T1",
      "T2_score": 26,
      "lead": 7,
      "raw_signal": 24.4
    }
  }
}